Goldman Sachs asks in biotech research report: ‘Is curing patients a sustainable business model?’ https://t.co/7yb2bAqcLF
— The Propell Group (@ThePropellGroup) April 19, 2018
Goldman Sachs asks in biotech research report: ‘Is curing patients a sustainable business model?’ https://t.co/7yb2bAqcLF
— The Propell Group (@ThePropellGroup) April 19, 2018